Frazier Lifesciences Acquisition Corp
DelistedCIK 1828326fmd_0C3X5EDW9683XHFT9AHA1WB8KNFinance, Insurance and Real Estate · Blank ChecksTemplate: Standard
Coverage: Jan 02, 2020 to Sep 30, 2022, 8 periods
Latest annual · FY2021
Millions- Operating income
- (1)
- Net income
- 4
Latest quarter · Q3 FY2022
Millions- Operating income
- (2)
- Net income
- (5)
Frazier Lifesciences Acquisition Corp financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.4 million | 10-K 2022-03-25 · proof | ||
| Net income | $4.2 million | 10-K 2022-03-25 · proof | ||
| Cash from operating activities | -$138,378 | 10-K 2022-03-25 · proof | ||
| Total assets | $139.5 million | $139.9 million | -0.3% | 10-K 2022-03-25 · proof |
| Total liabilities | $7.9 million | $12.4 million | -36.6% | 10-K 2022-03-25 · proof |
| Cash and cash equivalents | $1.2 million | $1.4 million | -10.1% | 10-K 2022-03-25 · proof |
- What was Frazier Lifesciences Acquisition Corp's operating income in fiscal 2021?
- Frazier Lifesciences Acquisition Corp reported operating income of -$1.4 million for fiscal 2021 (the year ended Dec 31, 2021). Source: the 10-K filed with the SEC on Mar 25, 2022. SEC
- What was Frazier Lifesciences Acquisition Corp's net income in fiscal 2021?
- Frazier Lifesciences Acquisition Corp reported net income of $4.2 million for fiscal 2021 (the year ended Dec 31, 2021). Source: the 10-K filed with the SEC on Mar 25, 2022. SEC
- What was Frazier Lifesciences Acquisition Corp's cash from operating activities in fiscal 2021?
- Frazier Lifesciences Acquisition Corp reported cash from operating activities of -$138,378 for fiscal 2021 (the year ended Dec 31, 2021). Source: the 10-K filed with the SEC on Mar 25, 2022. SEC
- What are Frazier Lifesciences Acquisition Corp's total assets?
- As of Dec 31, 2021, Frazier Lifesciences Acquisition Corp reported total assets of $139.5 million, against $139.9 million a year earlier (-0.3%). Source: the 10-K filed with the SEC on Mar 25, 2022. SEC
- What are Frazier Lifesciences Acquisition Corp's total liabilities?
- As of Dec 31, 2021, Frazier Lifesciences Acquisition Corp reported total liabilities of $7.9 million, against $12.4 million a year earlier (-36.6%). Source: the 10-K filed with the SEC on Mar 25, 2022. SEC
- What are Frazier Lifesciences Acquisition Corp's cash and cash equivalents?
- As of Dec 31, 2021, Frazier Lifesciences Acquisition Corp reported cash and cash equivalents of $1.2 million, against $1.4 million a year earlier (-10.1%). Source: the 10-K filed with the SEC on Mar 25, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1828326&period_type=annual&limit=5"Information only, not investment advice.